Le Lézard
Classified in: Science and technology, Business
Subjects: ACC, CXP

BlueVoyant Secures $68 Million in Third Round of Funding

NEW YORK, July 16, 2020 /PRNewswire/ -- BlueVoyant, a global expert-driven cybersecurity services company, announced today the close of a third round of funding. The $68 million financing round was led by Temasek, a global investment company headquartered in Singapore, and included participation from new and other existing investors. This brings total funding to $275 million to date.

This latest investment will enable the firm to accelerate its growth plans across its three key lines of business: Managed Security Services, for 24/7 detection and response inside customer networks; Third-Party Cyber Risk Services, providing supply chain and investment portfolio defense; and Cyber Defense Services, providing Incident Response, Defense Assessment, Brand Protection and Threat Intelligence.

BlueVoyant has offices in New York, Maryland, San Francisco, London, Madrid, Tel Aviv, and the Philippines, and has recently opened new offices in Central America.

"This latest round of funding will enable BlueVoyant to continue to service and build our ever-growing customer base, providing them with the most advanced cybersecurity defense capabilities," said Jim Rosenthal, co-founder, and CEO of BlueVoyant. "We are delighted to have generated such strong investor demand. This in turn helps us develop the managed services we offer; including combining our capabilities into our new Risk Operations Center to manage cyber risk for supply chains and investment portfolios. BlueVoyant has demonstrated its expertise and vision, identifying a clear market need for exceptional cybersecurity to defend both large and medium sized enterprises."

BlueVoyant, one of the fastest-growing global cybersecurity firms, helps businesses operationalize ecosystem-scale cybersecurity to protect effectively and efficiently. Since its inception in July 2017, the company has expanded its customer base to more than 300 clients across four continents in 16 different industries including: financial and business services, manufacturing, municipal government, healthcare and pharmaceutical, energy and utilities and the education sector.

About BlueVoyant

BlueVoyant is an expert-driven cybersecurity services company whose mission is to proactively defend organizations of all sizes against today's constant, sophisticated attackers and advanced threats. Led by CEO Jim Rosenthal, BlueVoyant's highly skilled team includes former government cyber officials with extensive frontline experience in responding to advanced cyber threats on behalf of the National Security Agency, Federal Bureau of Investigation, Unit 8200 and GCHQ, together with private sector experts. BlueVoyant services utilize large real-time datasets with industry leading analytics and technologies.

Founded in 2017 by Fortune 500 executives and former Government cyber officials and headquartered in New York City, BlueVoyant has offices in Maryland, Tel Aviv, San Francisco, London, Madrid and Latin America.

BlueVoyant Press Contacts

Danielle Ostrovsky
C8 Consulting (USA)
T: 001 410-302-9459
E: danielle@c8consulting.co.uk  

Jim Pople
C8 Consulting (EMEA)
T: +44 7955 030191
E: jim@c8consulting.co.uk

SOURCE BlueVoyant

These press releases may also interest you

at 22:35
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryngtm (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with...

at 22:00
Sfara revealed today its device testing program that evaluates and learns the capabilities and idiosyncrasies of various smartphone models, accelerating the development of mobile-based safety technologies for public infrastructure, consumers and...

at 21:30
Oucica, a Sub-brand of Huntkey, expert of air purification solutions will release its desktop air purifier DJ010 in the late of August. Like its previously released air purification products, the DJ010 is still developed and manufactured by...

at 20:37
Note: For the figures included in their FFSS, the Company has accounted for the effects of inflation adjustment adopted by Resolution 777/18 of the Comisión Nacional de Valores ("CNV"), which establishes that the restatement will be applied to the...

at 20:36
Swiss biotech company Memo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx's therapeutic COVID-19...

at 19:25
On August 16, The Ed Sullivan Show's official YouTube channel begins a tribute to one of rock 'n' roll music's most iconic talents with a special rollout of performances that spanned three appearances on The Ed Sullivan Show. That Elvis Presley...

News published on 16 july 2020 at 09:19 and distributed by: